scispace - formally typeset
S

Senthamaraikannan Kabilan

Researcher at Annamalai University

Publications -  145
Citations -  2025

Senthamaraikannan Kabilan is an academic researcher from Annamalai University. The author has contributed to research in topics: Antibacterial activity & Antimicrobial. The author has an hindex of 22, co-authored 141 publications receiving 1624 citations. Previous affiliations of Senthamaraikannan Kabilan include Instituto Superior de Engenharia de Lisboa.

Papers
More filters
Journal ArticleDOI

Synthesis, spectroscopic investigations (FT-IR, NMR, UV–Vis, and TD-DFT), and molecular docking of (E)-1-(benzo[d][1, 3]dioxol-6-yl)-3-(6-methoxynaphthalen-2-yl)prop-2-en-1-one

TL;DR: In this article, a novel compound (E )-1-(benzo [ d ] [1, 3] dioxol-6-yl)-3-(6-methoxy naphthalen-2-yl) prop-2en-1-one (AKN) was synthesized and characterized by FT-IR, NMR, and UV-Vis spectrometer.
Journal ArticleDOI

Chlorination of 2-phenoxypropanoic acid with NCP in aqueous acetic acid: using a novel ortho-para relationship and the para/meta ratio of substituent effects for mechanism elucidation.

TL;DR: Rate constants were measured for the oxidative chlorodehydrogenation of (R,S)-2-phenoxypropanoic acid and nine ortho-, ten para- and five meta-substituted derivatives using NCP as chlorinating agent, and a new approach is introduced for examining the effect of ortho substituents on reaction rates.
Journal ArticleDOI

Synthesis, spectral, crystal and theoretical studies of some novel 4-heterocyclic substituted pyrazolones

TL;DR: In this paper, pyrazolone ketene dithioacetals with various binucleophiles were characterized by IR, 1H, 13C, 2D NMR and X-ray diffraction techniques.
Journal ArticleDOI

Synthesis of some benzoxazolylethoxypiperidones

TL;DR: In this article, the authors synthesize a system which combines both biolabile piperidines and benzoxazole components together to give a compact structure like title compounds.
Journal ArticleDOI

Design, 3D QSAR modeling and docking of TGF-β type I inhibitors to target cancer.

TL;DR: The present study aimed to screen the potent TGF-β type I inhibitors through atom based 3D-QSAR and pharmacophore modelling, and obtained 7 distinct drug-like T GF-βtype I inhibitors which can be beneficial in suppressing cancers reported with up-regulation of TGF, β type I.